Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaolong Yang

Showing results (1-10 of 515) with videos related to

Pageof 52
Sort By:
SLAS Technology|August 18, 2024
Establishment and validation of a risk stratification model for stroke risk within three years in patients with cerebral small vessel disease using a combined MRI and machine learning algorithmXiaolong Yang, Hui Chang
Biosensors|December 27, 2024
Application of Fluorescence- and Bioluminescence-Based Biosensors in Cancer Drug DiscoveryTynan Kelly, Xiaolong Yang
Cell Research|April 13, 2011
Molecular mechanism of size control in development and human diseasesXiaolong Yang, Tian Xu
Cell Cycle (Georgetown, Tex.)|October 12, 2010
LATS tumor suppressor: a new governor of cellular homeostasisStacy Visser, Xiaolong Yang
Molecular Medicine Reports|June 5, 2013
Berberine induces selective apoptosis through the AMPK‑mediated mitochondrial/caspase pathway in hepatocellular carcinomaXiaolong Yang, Ning Huang
Cellular Signalling|May 16, 2013
BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZDulcie Lai, Xiaolong Yang
Cancers|November 8, 2018
Targeting the Hippo Pathway for Breast Cancer TherapyLiqing Wu, Xiaolong Yang
Oncotarget|July 18, 2015
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signallingYulei Zhao, Xiaolong Yang
International Journal of Cancer|October 29, 2014
The Hippo pathway in chemotherapeutic drug resistanceYulei Zhao, Xiaolong Yang
Methods in Molecular Biology (Clifton, N.J.)|July 14, 2022
Monitoring Hippo Signaling Pathway Activity Using a Luciferase-Based Large Tumor Suppressor (LATS) BiosensorAlexander Pipchuk, Xiaolong Yang
Pageof 52

Showing results (1-10 of 515) with videos related to

Sort By:
Pageof 52
SLAS Technology|August 18, 2024
Establishment and validation of a risk stratification model for stroke risk within three years in patients with cerebral small vessel disease using a combined MRI and machine learning algorithmXiaolong Yang, Hui Chang
Biosensors|December 27, 2024
Application of Fluorescence- and Bioluminescence-Based Biosensors in Cancer Drug DiscoveryTynan Kelly, Xiaolong Yang
Cell Research|April 13, 2011
Molecular mechanism of size control in development and human diseasesXiaolong Yang, Tian Xu
Cell Cycle (Georgetown, Tex.)|October 12, 2010
LATS tumor suppressor: a new governor of cellular homeostasisStacy Visser, Xiaolong Yang
Molecular Medicine Reports|June 5, 2013
Berberine induces selective apoptosis through the AMPK‑mediated mitochondrial/caspase pathway in hepatocellular carcinomaXiaolong Yang, Ning Huang
Cellular Signalling|May 16, 2013
BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZDulcie Lai, Xiaolong Yang
Cancers|November 8, 2018
Targeting the Hippo Pathway for Breast Cancer TherapyLiqing Wu, Xiaolong Yang
Oncotarget|July 18, 2015
Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signallingYulei Zhao, Xiaolong Yang
International Journal of Cancer|October 29, 2014
The Hippo pathway in chemotherapeutic drug resistanceYulei Zhao, Xiaolong Yang
Methods in Molecular Biology (Clifton, N.J.)|July 14, 2022
Monitoring Hippo Signaling Pathway Activity Using a Luciferase-Based Large Tumor Suppressor (LATS) BiosensorAlexander Pipchuk, Xiaolong Yang
Pageof 52